Cointime update: Johnson & Johnson has agreed to acquire biopharmaceutical company Ollin Biosciences for up to $3.33 billion, the company announced. The deal values Ollin at a headline figure of as much as $3.33 billion, though the structure of the consideration was not immediately detailed. Ollin is a biopharmaceutical company.
Johnson & Johnson to acquire Ollin Biosciences for up to $3.33B
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
11m ago
BofA: General-IT NAND Prices to Fall Another 5–10% in Q1
48m ago
CIBC to Launch Canadian Depositary Receipts for Anthropic After IPO
1h ago
Strive Buys 251 BTC for $17.5M, Holdings Reach 43,404 BTC
1h ago
Strategy Adds 485 Bitcoin, Total Holdings Reach 850,849 BTC
3h ago
IMF’s Georgieva Warns AI Circular Financing Tops $1 Trillion
3h ago
MUFG: BOJ to Raise Rates Further, Supporting Yen